Nan Fung Group Holdings Ltd
$131M
25
82.4%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 MPLT | $34.8M | 26.47% | 2.14% | Not reported | Q4 2025 |
 LBRX | $20.5M | 15.57% | 2.20% | Not reported | Q3 2025 |
 EVMN | $19.2M | 14.56% | 3.97% | Not reported | Q4 2025 |
 HELP | $6.53M | 4.96% | 1.91% | +114.6% | Q4 2025 |
 INCY | $6.09M | 4.63% | 0.03% | Not reported | Q4 2021 |
 RYTM | $5.45M | 4.15% | 0.07% | Not reported | Q4 2022 |
 ONC | $4.48M | 3.41% | 0.00% | Not reported | Q4 2021 |
 OCS | $4.17M | 3.17% | Not reported | -14.3% | Q1 2023 |
 ASND | $3.63M | 2.76% | 0.02% | Not reported | Q4 2021 |
 RVMD | $3.61M | 2.74% | 0.01% | Not reported | Q1 2024 |
 KYMR | $3.54M | 2.69% | 0.04% | Not reported | Q4 2021 |
 MDGL | $3.05M | 2.32% | 0.02% | Not reported | Q4 2022 |
 CELC | $2.96M | 2.25% | 0.06% | Not reported | Q1 2026 |
 ACAD | $2.61M | 1.98% | 0.06% | Not reported | Q4 2021 |
 ARGX | $2.6M | 1.98% | 0.00% | Not reported | Q4 2021 |
 RXRX | $2.18M | 1.66% | 0.11% | Not reported | Q4 2024 |
 PCOR | $2.17M | 1.65% | 0.04% | Not reported | Q4 2025 |
 HRMY | $985K | 0.75% | 0.05% | Not reported | Q2 2021 |
 INSM | $702K | 0.53% | 0.00% | Not reported | Q1 2026 |
 ETHA | $601K | 0.46% | 0.01% | Not reported | Q3 2025 |
| IBIT | $532K | 0.40% | 0.00% | Not reported | Q3 2025 |
 CHYM | $432K | 0.33% | 0.03% | New | Q2 2026 |
 RANI | $375K | 0.29% | Not reported | Not reported | Q3 2021 |
 TRDA | $361K | 0.27% | 0.13% | Not reported | Q1 2022 |
 BOLT | $19.3K | 0.01% | 0.26% | -82.9% | Q2 2021 |
| Q1 2026 | |||||
| EVMN | $33.1M | 27.32% | 4.00% | Not reported | Q4 2025 |
| MPLT | $19.7M | 16.28% | 2.15% | Not reported | Q4 2025 |
| LBRX | $15.6M | 12.82% | 2.20% | +110.2% | Q3 2025 |
| OCS | $9.33M | 7.69% | Not reported | -31.9% | Q1 2023 |
| INCY | $5.06M | 4.17% | 0.03% | -9.0% | Q4 2021 |
| ONC | $4.67M | 3.85% | 0.00% | Not reported | Q4 2021 |
| RYTM | $4.27M | 3.52% | 0.07% | Not reported | Q4 2022 |
| CELC | $3.23M | 2.66% | 0.06% | New | Q1 2026 |
| ASND | $3.11M | 2.57% | 0.02% | Not reported | Q4 2021 |
| PCOR | $3.04M | 2.51% | 0.04% | Not reported | Q4 2025 |
| MDGL | $2.97M | 2.45% | 0.02% | -52.2% | Q4 2022 |
| KYMR | $2.57M | 2.12% | 0.04% | Not reported | Q4 2021 |
| ACAD | $2.29M | 1.89% | 0.06% | Not reported | Q4 2021 |
| HELP | $2.21M | 1.82% | 0.89% | Not reported | Q4 2025 |
| ARGX | $2.04M | 1.69% | 0.00% | Not reported | Q4 2021 |
| RVMD | $1.87M | 1.54% | 0.01% | Not reported | Q1 2024 |
| RXRX | $1.83M | 1.51% | 0.11% | Not reported | Q4 2024 |
| INSM | $1.08M | 0.89% | 0.00% | New | Q1 2026 |
| ETHA | $800K | 0.66% | 0.01% | Not reported | Q3 2025 |
| HRMY | $758K | 0.62% | 0.05% | Not reported | Q2 2021 |
| TRDA | $619K | 0.51% | 0.13% | Not reported | Q1 2022 |
| IBIT | $613K | 0.51% | 0.00% | Not reported | Q3 2025 |
| RANI | $363K | 0.30% | Not reported | Not reported | Q3 2021 |
| BOLT | $118K | 0.10% | 1.52% | -49.9% | Q2 2021 |
| Q4 2025 | |||||
| EVMN | $24.7M | 22.08% | 4.57% | New | Q4 2025 |
| MPLT | $17.1M | 15.27% | 2.21% | New | Q4 2025 |
| OCS | $10.3M | 9.20% | Not reported | Not reported | Q1 2023 |
| MDGL | $6.91M | 6.19% | 0.05% | Not reported | Q4 2022 |
| LBRX | $6.68M | 5.98% | 1.19% | Not reported | Q3 2025 |
| INCY | $5.83M | 5.22% | 0.03% | Not reported | Q4 2021 |
| RYTM | $5.26M | 4.71% | 0.07% | Not reported | Q4 2022 |
| ONC | $4.78M | 4.28% | 0.00% | Not reported | Q4 2021 |
| PCOR | $3.88M | 3.47% | 0.04% | New | Q4 2025 |
| HELP | $3.76M | 3.37% | 2.13% | New | Q4 2025 |
| ASND | $2.9M | 2.60% | 0.02% | Not reported | Q4 2021 |
| ACAD | $2.75M | 2.46% | 0.06% | Not reported | Q4 2021 |
| RXRX | $2.43M | 2.18% | 0.11% | Not reported | Q4 2024 |
 LAB | $2.41M | 2.16% | 0.49% | Not reported | Q1 2024 |
| KYMR | $2.4M | 2.15% | 0.04% | Not reported | Q4 2021 |
| ARGX | $2.35M | 2.11% | 0.00% | Not reported | Q4 2021 |
| RVMD | $1.53M | 1.37% | 0.01% | Not reported | Q1 2024 |
| ETHA | $1.13M | 1.01% | 0.01% | Not reported | Q3 2025 |
| HRMY | $1.01M | 0.91% | 0.05% | Not reported | Q2 2021 |
| IBIT | $793K | 0.71% | 0.00% | Not reported | Q3 2025 |
| RANI | $666K | 0.60% | Not reported | Not reported | Q3 2021 |
 REPL | $619K | 0.55% | 0.08% | Not reported | Q1 2022 |
| TRDA | $505K | 0.45% | 0.13% | Not reported | Q1 2022 |
 BCYC | $488K | 0.44% | 0.10% | Not reported | Q2 2024 |
| BOLT | $319K | 0.29% | 3.04% | Not reported | Q2 2021 |
 RKLB | $267K | 0.24% | 0.00% | -87.1% | Q3 2025 |
| BSLK | $32.4K | 0.03% | Not reported | Not reported | Q3 2024 |
| Q3 2025 | |||||
| OCS | $9.05M | 15.18% | Not reported | Not reported | Q1 2023 |
| MDGL | $5.45M | 9.13% | 0.05% | Not reported | Q4 2022 |
| ONC | $5.36M | 8.99% | 0.00% | Not reported | Q4 2021 |
| INCY | $5.01M | 8.40% | 0.03% | Not reported | Q4 2021 |
| RYTM | $4.96M | 8.32% | 0.07% | Not reported | Q4 2022 |
| LBRX | $4.74M | 7.95% | 1.19% | New | Q3 2025 |
 JOBY | $3.51M | 5.88% | 0.02% | New | Q3 2025 |
| RXRX | $2.91M | 4.87% | 0.12% | -10.4% | Q4 2024 |
| ASND | $2.7M | 4.54% | 0.02% | Not reported | Q4 2021 |
| LAB | $2.45M | 4.11% | 0.49% | Not reported | Q1 2024 |
| ACAD | $2.2M | 3.69% | 0.06% | Not reported | Q4 2021 |
| ARGX | $2.07M | 3.46% | 0.00% | Not reported | Q4 2021 |
| KYMR | $1.75M | 2.93% | 0.04% | Not reported | Q4 2021 |
| ETHA | $1.59M | 2.67% | 0.01% | New | Q3 2025 |
| RKLB | $1.42M | 2.37% | 0.01% | New | Q3 2025 |
| IBIT | $1.04M | 1.74% | 0.00% | New | Q3 2025 |
| RVMD | $899K | 1.51% | 0.01% | Not reported | Q1 2024 |
| HRMY | $745K | 1.25% | 0.05% | -92.7% | Q2 2021 |
| BCYC | $534K | 0.90% | 0.10% | Not reported | Q2 2024 |
| BOLT | $310K | 0.52% | 3.04% | Not reported | Q2 2021 |
| TRDA | $285K | 0.48% | 0.13% | Not reported | Q1 2022 |
| REPL | $267K | 0.45% | 0.08% | Not reported | Q1 2022 |
| RANI | $247K | 0.41% | Not reported | Not reported | Q3 2021 |
| BSLK | $153K | 0.26% | Not reported | Not reported | Q3 2024 |